MB "Biotechnologiniai projektai" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
129,665 |
- |
-35,661 |
-35,661 |
- |
11.63 |
-27.50 |
33,779 |
956 |
12,901 |
21,834 |
2023 |
---|
101,015 |
- |
-39,486 |
-39,486 |
- |
11.48 |
-39.09 |
-5,707 |
18,805 |
9,801 |
3,297 |
2024 |
---|
151,441 |
- |
-9,449 |
-9,449 |
- |
25.44 |
-6.24 |
-15,156 |
25,123 |
6,931 |
3,036 |
Register and
explore Okredo data2024 |
---|
151,441 |
- |
-9,449 |
-9,449 |
- |
25.44 |
-6.24 |
-15,156 |
25,123 |
6,931 |
3,036 |
Register and
explore Okredo data2024
Turnover (€)
151,441 €50 % *
Sales per employee (€)
-Profit before tax (€)
-9,449 €76 % *
Net Profit (€)
-9,449 €76 % *
Profit per employee (€)
-Total profitability (%)
25.44 %121.60 % *
Net profitability (%)
-6.24 %84.04 % *
Equity (€)
-15,156 €-166 % *
Amounts Payable And Liabilities (€)
25,123 €34 % *
Non-current Assets (€)
6,931 €-29 % *
CurrentAssets (€)
3,036 €-8 % *